These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

443 related articles for article (PubMed ID: 28679633)

  • 1. Identification of pathogenic gene mutations in
    Ito K; Patel PN; Gorham JM; McDonough B; DePalma SR; Adler EE; Lam L; MacRae CA; Mohiuddin SM; Fatkin D; Seidman CE; Seidman JG
    Proc Natl Acad Sci U S A; 2017 Jul; 114(29):7689-7694. PubMed ID: 28679633
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Functional Studies and In Silico Analyses to Evaluate Non-Coding Variants in Inherited Cardiomyopathies.
    Frisso G; Detta N; Coppola P; Mazzaccara C; Pricolo MR; D'Onofrio A; Limongelli G; Calabrò R; Salvatore F
    Int J Mol Sci; 2016 Nov; 17(11):. PubMed ID: 27834932
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Key Value of RNA Analysis of MYBPC3 Splice-Site Variants in Hypertrophic Cardiomyopathy.
    Singer ES; Ingles J; Semsarian C; Bagnall RD
    Circ Genom Precis Med; 2019 Jan; 12(1):e002368. PubMed ID: 30645170
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exome Sequencing Identifies a Novel LMNA Splice-Site Mutation and Multigenic Heterozygosity of Potential Modifiers in a Family with Sick Sinus Syndrome, Dilated Cardiomyopathy, and Sudden Cardiac Death.
    Zaragoza MV; Fung L; Jensen E; Oh F; Cung K; McCarthy LA; Tran CK; Hoang V; Hakim SA; Grosberg A
    PLoS One; 2016; 11(5):e0155421. PubMed ID: 27182706
    [TBL] [Abstract][Full Text] [Related]  

  • 5.
    Kato K; Ohno S; Sonoda K; Fukuyama M; Makiyama T; Ozawa T; Horie M
    Circ Genom Precis Med; 2020 Oct; 13(5):435-443. PubMed ID: 32818388
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New intronic splicing mutation in the LMNA gene causing progressive cardiac conduction defects and variable myopathy.
    Rogozhina Y; Mironovich S; Shestak A; Adyan T; Polyakov A; Podolyak D; Bakulina A; Dzemeshkevich S; Zaklyazminskaya E
    Gene; 2016 Dec; 595(2):202-206. PubMed ID: 27717888
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Genotype Complements the Phenotype: Identification of the Pathogenicity of an LMNA Splice Variant by Nanopore Long-Read Sequencing in a Large DCM Family.
    Sedaghat-Hamedani F; Rebs S; Kayvanpour E; Zhu C; Amr A; Müller M; Haas J; Wu J; Steinmetz LM; Ehlermann P; Streckfuss-Bömeke K; Frey N; Meder B
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36293084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Leveraging splice-affecting variant predictors and a minigene validation system to identify Mendelian disease-causing variants among exon-captured variants of uncertain significance.
    Soens ZT; Branch J; Wu S; Yuan Z; Li Y; Li H; Wang K; Xu M; Rajan L; Motta FL; Simões RT; Lopez-Solache I; Ajlan R; Birch DG; Zhao P; Porto FB; Sallum J; Koenekoop RK; Sui R; Chen R
    Hum Mutat; 2017 Nov; 38(11):1521-1533. PubMed ID: 28714225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Functional assessment of potential splice site variants in arrhythmogenic right ventricular dysplasia/cardiomyopathy.
    Groeneweg JA; Ummels A; Mulder M; Bikker H; van der Smagt JJ; van Mil AM; Homfray T; Post JG; Elvan A; van der Heijden JF; Houweling AC; Jongbloed JD; Wilde AA; van Tintelen JP; Hauer RN; Dooijes D
    Heart Rhythm; 2014 Nov; 11(11):2010-7. PubMed ID: 25087486
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification of novel mutations including a double mutation in patients with inherited cardiomyopathy by a targeted sequencing approach using the Ion Torrent PGM system.
    Zhao Y; Cao H; Song Y; Feng Y; Ding X; Pang M; Zhang Y; Zhang H; Ding J; Xia X
    Int J Mol Med; 2016 Jun; 37(6):1511-20. PubMed ID: 27082122
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Systematic Computational Identification of Variants That Activate Exonic and Intronic Cryptic Splice Sites.
    Lee M; Roos P; Sharma N; Atalar M; Evans TA; Pellicore MJ; Davis E; Lam AN; Stanley SE; Khalil SE; Solomon GM; Walker D; Raraigh KS; Vecchio-Pagan B; Armanios M; Cutting GR
    Am J Hum Genet; 2017 May; 100(5):751-765. PubMed ID: 28475858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multiple sequence variants of BRCA2 exon 7 alter splicing regulation.
    Gaildrat P; Krieger S; Di Giacomo D; Abdat J; Révillion F; Caputo S; Vaur D; Jamard E; Bohers E; Ledemeney D; Peyrat JP; Houdayer C; Rouleau E; Lidereau R; Frébourg T; Hardouin A; Tosi M; Martins A
    J Med Genet; 2012 Oct; 49(10):609-17. PubMed ID: 22962691
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Whole MYBPC3 NGS sequencing as a molecular strategy to improve the efficiency of molecular diagnosis of patients with hypertrophic cardiomyopathy.
    Janin A; Chanavat V; Rollat-Farnier PA; Bardel C; Nguyen K; Chevalier P; Eicher JC; Faivre L; Piard J; Albert E; Nony S; Millat G
    Hum Mutat; 2020 Feb; 41(2):465-475. PubMed ID: 31730716
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SEPT-GD: A decision tree to prioritise potential RNA splice variants in cardiomyopathy genes for functional splicing assays in diagnostics.
    Alimohamed MZ; Boven LG; van Dijk KK; Vos YJ; Hoedemaekers YM; van der Zwaag PA; Sijmons RH; Jongbloed JDH; Sikkema-Raddatz B; Westers H
    Gene; 2023 Jan; 851():146984. PubMed ID: 36270459
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A genome-first approach to aggregating rare genetic variants in LMNA for association with electronic health record phenotypes.
    Park J; Levin MG; Haggerty CM; Hartzel DN; Judy R; Kember RL; Reza N; ; Ritchie MD; Owens AT; Damrauer SM; Rader DJ
    Genet Med; 2020 Jan; 22(1):102-111. PubMed ID: 31383942
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein haploinsufficiency drivers identify MYBPC3 variants that cause hypertrophic cardiomyopathy.
    Suay-Corredera C; Pricolo MR; Herrero-Galán E; Velázquez-Carreras D; Sánchez-Ortiz D; García-Giustiniani D; Delgado J; Galano-Frutos JJ; García-Cebollada H; Vilches S; Domínguez F; Molina MS; Barriales-Villa R; Frisso G; Sancho J; Serrano L; García-Pavía P; Monserrat L; Alegre-Cebollada J
    J Biol Chem; 2021 Jul; 297(1):100854. PubMed ID: 34097875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of machine learning to classify high-risk variants of uncertain significance in lamin A/C cardiac disease.
    Bennett JS; Gordon DM; Majumdar U; Lawrence PJ; Matos-Nieves A; Myers K; Kamp AN; Leonard JC; McBride KL; White P; Garg V
    Heart Rhythm; 2022 Apr; 19(4):676-685. PubMed ID: 34958940
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of an elusive spliceogenic MYBPC3 variant in an otherwise genotype-negative hypertrophic cardiomyopathy pedigree.
    Torrado M; Maneiro E; Lamounier Junior A; Fernández-Burriel M; Sánchez Giralt S; Martínez-Carapeto A; Cazón L; Santiago E; Ochoa JP; McKenna WJ; Santomé L; Monserrat L
    Sci Rep; 2022 May; 12(1):7284. PubMed ID: 35508642
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Functional characterization of putative novel splicing mutations in the cardiomyopathy-causing genes.
    Millat G; Lafont E; Nony S; Rouvet I; Bozon D
    DNA Cell Biol; 2015 Jul; 34(7):489-96. PubMed ID: 25849606
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lamin A/C gene mutations in familial cardiomyopathy with advanced atrioventricular block and arrhythmia.
    Saga A; Karibe A; Otomo J; Iwabuchi K; Takahashi T; Kanno H; Kikuchi J; Keitoku M; Shinozaki T; Shimokawa H
    Tohoku J Exp Med; 2009 Aug; 218(4):309-16. PubMed ID: 19638735
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.